Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
AVITA Medical to Present at the Cantor Global Healthcare Conference
-
Adverum Biotechnologies to Participate in Upcoming Investor Conferences
-
NKGen Biotech to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
-
Elevar Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
-
Maze Therapeutics to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023
-
Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference
-
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
-
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
-
Spero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conference
-
Veru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023
-
Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
-
Gorilla Technology Group (GRRR) Announce $25M Convertible Stock Offering
-
Clear Street Appoints Former Morgan Stanley Technology Leader Jon Daplyn as Chief Information Officer
-
Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences
-
NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
-
Gorilla Announces $25 Million Registered Direct Offering of Convertible Preferred Stock
-
IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
-
Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
-
Satellos to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023
-
NUTEX HEALTH ANNOUNCES PARTICIPATION IN THE 2023 CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE
-
Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Form 424B3 Cantor Fitzgerald Income
-
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Vaxcyte to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023
-
Icosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023
-
BioVie to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
-
Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare Conference
-
Cantor Fitzgerald Starts Akero Therapeutics (AKRO) at Overweight, 'Positive on Upcoming F4 NASH Readout'
-
SELLAS Life Sciences to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
-
Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Danny Salinas Joins Cantor Fitzgerald as Chief Financial Officer
-
Jasper Therapeutics to Present at the Cantor Fitzgerald 2023 Global Healthcare Conference
-
CymaBay Announces Closing of Upsized $258.7 Million Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Jazz Pharmaceuticals to Participate in Three Upcoming Investor Conferences
-
Cantor Fitzgerald and BGC Group Raise Spirits and Funds with Charity Day 2023
-
BGC Group and Cantor Fitzgerald Raise Spirits and Funds with Charity Day 2023

